Testing the nonclinical Comprehensive In Vitro Proarrhythmia Assay (CiPA) paradigm with an established anti‐seizure medication: Levetiracetam case study.
Saved in:
| Title: | Testing the nonclinical Comprehensive In Vitro Proarrhythmia Assay (CiPA) paradigm with an established anti‐seizure medication: Levetiracetam case study. |
|---|---|
| Authors: | Delaunois, Annie1 (AUTHOR) annie.delaunois@ucb.com, Mathy, François‐Xavier1 (AUTHOR), Cornet, Miranda1 (AUTHOR), Gryshkova, Vitalina1 (AUTHOR), Korlowski, Chloé1 (AUTHOR), Bonfitto, François2 (AUTHOR), Koch, Juliane3 (AUTHOR), Schlit, Anne‐Françoise2 (AUTHOR), Hebeisen, Simon4 (AUTHOR), Passini, Elisa5 (AUTHOR), Rodriguez, Blanca5 (AUTHOR), Valentin, Jean‐Pierre1 (AUTHOR) |
| Source: | Pharmacology Research & Perspectives. Feb2023, Vol. 11 Issue 1, p1-13. 13p. |
| Database: | Academic Search Ultimate |
| ISSN: | 20521707 |
|---|---|
| DOI: | 10.1002/prp2.1059 |
